Navigation Links
Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac

It has been proposed by Pharmac, to hold a meeting regarding extension of funding for the cancer drug Herceptin that would allow the provision of drug to women with early breast cancer. // Currently, funding can only be availed by patients with advanced breast cancer. Extension of the budget for the cancer from the existing $47 million to $77 million has been planned.

The company officials are much more bothered about the safety and efficacy of the anti-cancer drug that is being assessed, according to Dr Peter Moodie, Medical Director, Pharmac. He further stated that the company officials are being open minded about the issue and are really interested in the drug.

The authorization body, Medsafe is yet to approve the proposal of the Pharmac's Pharmacology Therapeutics Advisory Committee.

HER2 positive cancers, an aggressive form account for 30% of all breast cancers against which Herceptin has been shown to be effective. Although previous studies have been able to demonstrate a 46% improved survival rate in those who received the drug and a decreased recurrence rate, the cost constraint has limited widespread use of drug.

Libby Burgess, Chairwoman, Breast Cancer Advocacy Coalition is very hopeful that a lot of valuable lives can be saved by the investment. Most women in New Zealand face severe financial constraints to enable breast cancer treatment. In fact, some even go to the extent of mortgaging their house. Nearly 2500 women in New Zealand are being diagnosed with breast cancer every year.

Pharmac and Roche Products are locally supplying the anti-cancer drug in New Zealand. The pharmaceutical companies are closely working together to extend the available funding. A spokesman for Roche announced that the assessment process is being fast-tracked.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... , ... August 17, 2017 , ... Inc. Magazine Unveils ... at No. 132 with Three-Year Sales Growth of 3,004.8% , NEW YORK, August 16, ... Inc. 5000, the most prestigious ranking of the nation's fastest-growing private companies. The list ...
(Date:8/17/2017)... , ... August 17, 2017 , ... ... Employers , an international competition, were announced today. The awards recognize the world’s ... suppliers who help to create and drive great places to work. , A ...
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) ... President, Chief Medical Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, ... for BHI’s cutting-edge analytics solutions. , “I am thrilled to welcome Dr. Spiro ...
(Date:8/16/2017)... Atlanta, GA (PRWEB) , ... August 16, 2017 , ... ... the new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... The list represents a unique look at the most successful companies within the American ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... their recently launched community enrichment program. Partnering once again with Boys & Girls ... competition to help find the area’s very own American Idol. With all proceeds ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... AROMAS, Calif. , Aug. 2, 2017 /PRNewswire/ ... by Continental Who,s Who as a Pinnacle Lifetime ... currently the Key Account Manager at Turing Pharmaceuticals, ... communications, negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience ...
(Date:7/31/2017)... FLINT, Mich. , July 31, 2017  Diplomat Pharmacy, ... companies in southeast Michigan by ... feature ranks private and public companies by three-year revenue growth. ... To view the complete list, ... Crain,s Fast 50 is an incredible triumph," said Phil ...
(Date:7/27/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported ... The Company reported second quarter net sales of $1.954 ... period, and an increase of 2.1% on a constant ... from the LDR Holding Corporation acquisition, second quarter 2017 ... or 0.3% on a constant currency basis. ...
Breaking Medicine Technology: